Penumbra, Inc. (PEN) is a publicly traded Healthcare sector company. As of August 19, 2026, PEN trades at $324.65 with a market cap of $12.89B and a P/E ratio of 79.83. PEN moved -0.74% today. Year to date, PEN is +4.45%; over the trailing twelve months it is +27.18%. Its 52-week range spans $221.26 to $362.41. Analyst consensus is neutral with an average price target of $358.40. Rallies surfaces PEN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for PEN shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $324.65 |
| Market Cap | $12.89B |
| P/E Ratio | 79.83 |
| EPS | $4.09 |
| Dividend Yield | 0.00% |
| 52-Week High | $362.41 |
| 52-Week Low | $221.26 |
| Volume | 142.91K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.50B |
| Net Income | $160.59M |
| Gross Margin | 67.84% |
6 analysts cover PEN: 0 strong buy, 1 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $358.40.